A Controlled Trial Comparing One-Year Hemodynamics of Two Bovine Pericardial Valves
The Thoracic and Cardiovascular Surgeon · 01.03.2025 · 73 (02) · 132-140
DOI: 10.1055/a-2199-2087 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift The Thoracic and Cardiovascular Surgeon, erschienen am 01.03.2025. Verfasst von Suk Ho Sohn und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic…. Hauptthemen laut MEDLINE: Aortic Valve, Aortic Valve Stenosis, Bioprosthesis, Heart Valve Prosthesis. Die Arbeit nennt 24 Literaturangaben.
Abstract (Originalsprache)
Background
This randomized controlled trial was designed to compare 1-year hemodynamic performances and clinical outcomes after aortic valve replacement (AVR) using a recently introduced (the AVALUS group) and worldwide used (the CEPME group) bovine pericardial bioprostheses.
Methods
Patients were screened to enroll 70 patients in each group based on a noninferiority design. The primary endpoint of the trial was the mean pressure gradient across the aortic valve (AVMPG) at 1 year after surgery. One-year echocardiographic data were obtained from 92.1% (129 of 140 patients) of the study patients.
Results
There were no differences in baseline characteristics, including sex and body surface area (1.64 ± 0.18 vs. 1.65 ± 0.15 m2) between the groups. The AVMPG on 1-year echocardiography was 14.0 ± 4.3 and 13.9 ± 5.1 mmHg in the AVALUS and CEPME groups, respectively (the p-value for noninferiority was 0.0004). In the subgroup analyses for the respective size of the prostheses, AVMPG of the 19-mm prostheses was significantly lower in the AVALUS group than in the CEPME group (14.0 ± 4.3 vs. 20.0 ± 4.7 mmHg, p = 0.012), whereas those of the other sizes were not significantly different between the two groups. There were no significant differences in the effective orifice area (1.49 ± 0.40 vs. 1.53 ± 0.38 cm2, p = 0.500) or effective orifice area index (0.91 ± 0.22 vs 0.93 ± 0.23 cm2/m2, p = 0.570) in all the patients, or in the subgroup analysis for the 19-mm prosthesis. There were no differences in the 1-year clinical outcomes between the two groups.
Conclusion
The 1-year hemodynamic and clinical outcomes of the AVALUS group were noninferior to those of the CEPME group (NCT03796442).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.
- Department of Thoracic and Cardiovascular Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Republic of Korea.
ORCID-Profile: Jae Hang Lee
Zitieren
APA
Sohn, S. H., Kang, Y., Kim, J. S., Choi, J. W., Lee, J. H., Kim, J. S., Lim, C., & Hwang, H. Y. (2025). A Controlled Trial Comparing One-Year Hemodynamics of Two Bovine Pericardial Valves. The Thoracic and Cardiovascular Surgeon, 73(02), 132-140. https://doi.org/10.1055/a-2199-2087
Vancouver
Sohn SH, Kang Y, Kim JS, Choi JW, Lee JH, Kim JS, et al. A Controlled Trial Comparing One-Year Hemodynamics of Two Bovine Pericardial Valves. The Thoracic and Cardiovascular Surgeon. 2025;73(02):132-140. doi:10.1055/a-2199-2087
BibTeX
@article{Sohn2025,
author = {Sohn, Suk Ho and Kang, Yoonjin and Kim, Ji Seong and Choi, Jae Woong and Lee, Jae Hang and Kim, Jun Sung and Lim, Cheong and Hwang, Ho Young},
title = {A Controlled Trial Comparing One-Year Hemodynamics of Two Bovine Pericardial Valves},
journal = {The Thoracic and Cardiovascular Surgeon},
year = {2025},
volume = {73},
number = {02},
pages = {132--140},
doi = {10.1055/a-2199-2087}
}
EUVIMED